Cargando…
Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines
Long COVID is characterized by the emergence of multiple debilitating symptoms following SARS-CoV-2 infection. Its etiology is unclear and it often follows a mild acute illness. Anecdotal reports of gradual clinical responses to histamine receptor antagonists (HRAs) suggest a histamine-dependent mec...
Autores principales: | Glynne, Paul, Tahmasebi, Natasha, Gant, Vanya, Gupta, Rajeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494538/ https://www.ncbi.nlm.nih.gov/pubmed/34611034 http://dx.doi.org/10.1136/jim-2021-002051 |
Ejemplares similares
-
Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection
por: Pinto, Melissa D., et al.
Publicado: (2022) -
Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms
por: Gupta, Rajeev, et al.
Publicado: (2020) -
Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities
por: Villoutreix, Bruno O, et al.
Publicado: (2021) -
Ambivalent antihistamines.
Publicado: (1994) -
Pharmacology of Antihistamines
por: Church, Martin K, et al.
Publicado: (2013)